Investec Bank plc has filed a Form 8.5 regulatory disclosure detailing its dealings in Advanced Medical Solutions Group plc (AMS.L) shares on 18th June 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders acting in a client-serving capacity.
Investec Bank plc holds the position of adviser and joint broker to Advanced Medical Solutions Group plc, giving it recognised intermediary status under the Code.
The filing reveals that Investec purchased a total of 109,174 ordinary shares in Advanced Medical Solutions Group on the dealing date.
The highest price paid per unit in those purchases was 229 pence, while the lowest price paid came in at 227 pence per share.
On the same date, Investec also sold 59,174 ordinary shares in the company, with prices ranging between 227.5 pence and 228 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were recorded as part of this particular disclosure filing.
Investec confirmed there are no indemnity or option arrangements, nor any agreements or understandings that could serve as an inducement to deal or refrain from dealing.
The bank also stated there are no agreements or understandings relating to voting rights or the future acquisition or disposal of relevant securities tied to any derivative instrument.
The disclosure was formally dated 19th June 2026, with contact for the filing attributed to Abhishek Gawde, reachable via the telephone number listed in the regulatory submission.
Advanced Medical Solutions Group plc, trading on the London Stock Exchange under the ticker AMS.L, was up 2.19% at the time of the disclosure being circulated.
Rule 8 disclosures of this nature are required to be submitted to a Regulatory Information Service, ensuring transparency around share dealings during offer periods under the Takeover Code.
